GL
Geulah Livshits Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
90
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $17 |
130%
upside
| 3 | +16% |
0
%
| 13 Jan ‘26 5 days ago |
|
|
|
Buy
Maintained
| $12 |
163%
upside
| 2 | +22% |
0
%
| 6 Jan ‘26 12 days ago |
|
|
|
Buy
Maintained
| $26 |
244%
upside
| 2 | +9.1% |
0
%
| 18 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $174 |
74%
upside
| 3 | +35% |
0
%
| 16 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $8 |
997%
upside
| 2 | +17% |
0
%
| 12 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $13 |
1,162%
upside
| 1 | -15% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $74 |
38%
upside
| 1 | +7% |
0
%
| 26 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $25 |
154%
upside
| 1 | -3.6% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $20 |
337%
upside
| 1 | +32% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $21 |
63%
upside
| 1 | +17% |
0
%
| 12 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $9 |
126%
upside
| 1 | +20% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $26 |
108%
upside
| 2 | +19% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $17 |
620%
upside
| 1 | -8.6% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $15 |
174%
upside
| 1 | +16% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $220 |
23%
downside
| 1 | +11% |
0
%
| 4 Nov ‘25 2 months ago |
|